ABSTRACT
Some studies have suggested an overlap of clinical and genetic findings between essential tremor (ET) and Parkinson's disease (PD). The first genome-wide association study in ET showed a significant association with the rs9652490 SNP of the leucine-rich repeat and Ig domain containing 1 (LINGO1) gene. Since patients with PD have higher LINGO1 expression levels compared to healthy controls, and animal models of PD show elevated LINGO1 protein levels after experimentally induced damage in the striatum, it can be inferred that LINGO1 is probably involved in PD pathophysiology. In this study, we performed a genetic association analysis of the rs9652490 and rs11856808 SNPs in Italian PD patients and controls to assess the role of these variants in our population. A total of 567 patients with PD and 468 control subjects were enrolled in five Movement Disorder centers located in Central-Southern Italy. Both variants were significantly associated with PD under a recessive model of inheritance before applying the Bonferroni correction. The GG genotype of rs9652490 and the TT genotype of rs11856808 were less frequent in patients than in controls, suggesting a protective effect against the disease. However, after stringent correction, only the P-values obtained from allele and genotype comparisons of the rs11856808 SNP remained significant. Our findings suggest that LINGO1 plays a certain role in the development of PD in the Italian population and represents an interesting candidate gene responsible for PD, due to its involvement in neurological processes.
Subject(s)
Genome-Wide Association Study/methods , Membrane Proteins/genetics , Nerve Tissue Proteins/genetics , Parkinson Disease/genetics , Aged , Cohort Studies , Female , Humans , Italy/epidemiology , Italy/ethnology , Male , Middle Aged , Parkinson Disease/epidemiology , Parkinson Disease/ethnology , Polymorphism, Single Nucleotide/geneticsABSTRACT
The SCA17 clinical phenotype includes characteristics associated with cerebellar and cortical atrophy such as ataxia, dementia, epilepsy, chorea and parkinsonian features. Here we describe the case of a 38-year-old male presenting with ataxia, cognitive impairment and seizures, who was found to carry 43 repeats on one allele of the TATA-binding protein (TBP) gene. Therefore, genetic analysis of TBP gene triplets was performed on the patient's entire family, identifying three asymptomatic carriers of the same allele. A neuroradiological phenotype appeared to segregate with this allele, suggesting that it may play at least a contributory role in the determination of SCA17.
Subject(s)
Ataxia/genetics , Cognition Disorders/genetics , Seizures/genetics , TATA-Box Binding Protein/genetics , Adult , Alleles , Humans , Male , Pedigree , Phenotype , Trinucleotide Repeat ExpansionABSTRACT
Cortical thickness has been proposed as a new promising brain imaging endophenotype in elucidating the nature of gene-brain relationships. Here, we define the morphological impact of the Val(158)Met polymorphism in the catechol-O-methyltransferase (COMT) gene on human brain anatomy. One hundred and forty-nine adult healthy subjects (mean age: 40.7+/-16.1; ranging from 19 to 76 years) were genotyped (38 in the homozygous Val(158) group; 80 in the Val(158)Met group; 31 in the homozygous Met(158) group) for the COMT polymorphism and underwent morphological examination. Surface-based analysis of the cortical mantle showed that the COMT genotype was associated with structural differences in the right superior temporal sulcus and inferior prefrontal sulcus, where the individuals carrying the Met(158) allele had a thicker cortex with respect to their Val(158) counterparts. Our study extends the previous evidence found on pediatric population to the adult population, demonstrating that the higher synaptic dopamine levels associated with the presence of the Met(158) allele may influence neuronal architecture in brain structures important for executive and emotional processing.
Subject(s)
Catechol O-Methyltransferase/genetics , Cerebral Cortex/enzymology , Cerebral Cortex/growth & development , Dopamine/biosynthesis , Methionine/genetics , Polymorphism, Genetic/genetics , Adult , Aged , Amino Acid Substitution/genetics , Body Patterning/genetics , Cerebral Cortex/anatomy & histology , DNA Mutational Analysis , Female , Genetic Testing , Genetic Variation/genetics , Genotype , Humans , Male , Middle Aged , Organogenesis/genetics , Phenotype , Point Mutation/genetics , Prefrontal Cortex/anatomy & histology , Prefrontal Cortex/enzymology , Prefrontal Cortex/growth & development , Temporal Lobe/anatomy & histology , Temporal Lobe/enzymology , Temporal Lobe/growth & development , Young AdultABSTRACT
Mutations in the gene DJ-1 have been shown to be a rare cause of early-onset Parkinson's disease (EOPD). Since DJ-1 mutations have been found in patients with Parkinson's disease (PD) from southern Italy, we aimed to investigate whether polymorphisms within the DJ-1 gene could represent a risk factor for sporadic PD. First, we genotyped 294 patients with PD and 298 controls coming from southern Italy to assess the distribution of the insertion/deletion (Ins/Del) polymorphism. In a second phase, we identified five single-nucleotide polymorphisms (SNPs) useful to delimit a region potentially involved and genotyped all patients and controls for these markers. All the markers analyzed were significantly associated with PD at both allelic and genotypic level. The most significant association with the disease was found at the Ins/Del polymorphism (p = 0.0001; adjusted odds ratio (OR ) = 2.05; confidence interval (CI ) = 1.36-3.08). When we considered a three-marker sliding window, we found a highly significant association between the disease and the haplotypes including markers rs17523802, Ins/Del, and rs3766606 (p = 0.0007) and markers Ins/Del, rs3766606 and rs7517357 (p = 0.0054). Our results indicate that polymorphisms located in a region spanning 3535 bp from the promoter to the intron 2 of the DJ-1 gene confer risk to sporadic PD in southern Italy.
Subject(s)
Genetic Predisposition to Disease , Intracellular Signaling Peptides and Proteins/genetics , Oncogene Proteins/genetics , Parkinson Disease/genetics , Polymorphism, Genetic , Adult , Aged , Aged, 80 and over , Female , Genetic Markers , Genotype , Humans , Italy , Male , Middle Aged , Protein Deglycase DJ-1 , Risk FactorsABSTRACT
BACKGROUND: Recent studies indicate an increased frequency of mutations in the gene encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among patients with Parkinson's disease. We aimed to ascertain the frequency of GBA mutations in an ethnically diverse group of patients with Parkinson's disease. METHODS: Sixteen centers participated in our international, collaborative study: five from the Americas, six from Europe, two from Israel, and three from Asia. Each center genotyped a standard DNA panel to permit comparison of the genotyping results across centers. Genotypes and phenotypic data from a total of 5691 patients with Parkinson's disease (780 Ashkenazi Jews) and 4898 controls (387 Ashkenazi Jews) were analyzed, with multivariate logistic-regression models and the Mantel-Haenszel procedure used to estimate odds ratios across centers. RESULTS: All 16 centers could detect two GBA mutations, L444P and N370S. Among Ashkenazi Jewish subjects, either mutation was found in 15% of patients and 3% of controls, and among non-Ashkenazi Jewish subjects, either mutation was found in 3% of patients and less than 1% of controls. GBA was fully sequenced for 1883 non-Ashkenazi Jewish patients, and mutations were identified in 7%, showing that limited mutation screening can miss half the mutant alleles. The odds ratio for any GBA mutation in patients versus controls was 5.43 across centers. As compared with patients who did not carry a GBA mutation, those with a GBA mutation presented earlier with the disease, were more likely to have affected relatives, and were more likely to have atypical clinical manifestations. CONCLUSIONS: Data collected from 16 centers demonstrate that there is a strong association between GBA mutations and Parkinson's disease.
Subject(s)
Glucosylceramidase/genetics , Mutation , Parkinson Disease/genetics , Aged , Case-Control Studies , Genotype , Humans , Jews/genetics , Logistic Models , Middle Aged , Multivariate Analysis , Odds RatioSubject(s)
Epilepsies, Myoclonic/genetics , Mutation , Nerve Tissue Proteins/genetics , Nucleotides/genetics , Sodium Channels/genetics , Base Sequence , Case-Control Studies , Codon , DNA Mutational Analysis , Gene Deletion , Humans , Infant, Newborn , Introns , Italy , Molecular Sequence Data , NAV1.1 Voltage-Gated Sodium ChannelABSTRACT
The human DRD2 gene is located on chromosome 11q22-q23 and contains one specific functional polymorphism called TaqIA, which characteristically presents two alleles referred to as A1 and A2. Evidence indicates that the A1 allele impacts brain dopaminergic function and may confer an increased risk of developing Parkinson's disease. However, possible morphological changes underlying such genetic variant remain to be clarified. The aim of this study was to provide an in vivo demonstration of changes in brain structures associated with the TaqIA polymorphism of the DRD2 gene. Optimized voxel-based morphometry (VBM) was applied to high-resolution MR brain images of 70 healthy controls divided into two groups according to their DRD2 genotype (A1/A2, n = 15; A2/A2, n = 55). Compared with individuals' homozygous for the A2 allele, the A1 carriers had significantly smaller areas of a specific part of the midbrain, encompassing the substantia nigra bilaterally. Our findings showed an association of the DRD2 TaqIA polymorphism with the changed volumes of a specific subcortical region strongly involved in the dopaminergic system.
Subject(s)
Mesencephalon/anatomy & histology , Receptors, Dopamine D2/genetics , Adult , Cognition/physiology , DNA/genetics , Female , Gene Frequency , Genotype , Humans , Italy/epidemiology , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests , Polymorphism, Genetic/genetics , Reference Values , Young AdultABSTRACT
Dementia is a common complication of Parkinson's disease (PD). It correlates significantly with the presence of cortical, limbic or nigral Lewy bodies, mainly constituted of alpha-synuclein. Mutations of the alpha-synuclein gene (SNCA) have been linked to rare familial forms of PD, while association studies on the promoter polymorphisms have given conflicting results in sporadic patients. We have performed a case control study to investigate whether genetic variability in the promoter of the alpha-synuclein gene could predispose to dementia in PD. A total of 114 demented patients and 114 non-demented patients with sporadic PD were included in the study. Six polymorphic loci (including the Rep1 microsatellite) in the promoter of the SNCA gene were examined. Each marker, taken individually, did not show association to dementia and no significant differences were observed in the inferred haplotype frequencies of demented and non-demented patients. Our data suggest the lack of involvement of the SNCA promoter in the pathogenesis of dementia in PD. Further studies in other populations are needed to confirm these results.
Subject(s)
Dementia/genetics , Haplotypes , Parkinson Disease/genetics , Promoter Regions, Genetic , alpha-Synuclein/genetics , Aged , Female , Humans , Male , Middle Aged , Polymorphism, GeneticSubject(s)
Gene Dosage , Nerve Tissue Proteins/genetics , Spinocerebellar Ataxias/genetics , Adult , Age of Onset , Aged , Alleles , Ataxins , Family Health , Female , Genes, Dominant , Humans , Male , Middle Aged , Nucleotides/genetics , PedigreeSubject(s)
Parkinson Disease/genetics , Point Mutation , Protein Serine-Threonine Kinases/genetics , Adult , Age of Onset , Aged , Aged, 80 and over , Case-Control Studies , Female , Genes, Dominant , Haplotypes , Heterozygote , Humans , Italy , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 , Male , Middle AgedSubject(s)
Chylomicrons/metabolism , Guanine Nucleotide Exchange Factors/genetics , Hypobetalipoproteinemia, Familial, Apolipoprotein B/genetics , Monomeric GTP-Binding Proteins/genetics , Mutation , Spinocerebellar Degenerations/genetics , Base Sequence , Homozygote , Humans , Male , Molecular Sequence Data , Pedigree , Sequence Analysis, DNA , Vitamin E/bloodSubject(s)
Hypotension/genetics , Nerve Tissue Proteins/genetics , RNA-Binding Proteins/genetics , Tremor/genetics , Trinucleotide Repeats , Aged , Alleles , Blood Pressure Monitoring, Ambulatory , Fragile X Mental Retardation Protein , Heterozygote , Humans , Male , Postprandial Period , Promoter Regions, Genetic/geneticsABSTRACT
We investigated the segregation of the dinucleotide GT repeat polymorphism in the intron between exons 9 and 10 of the tau gene in 300 patients with Parkinson's disease (PD) and in 197 normal controls. The A3 allele was more frequent in cases than in controls (30% versus 16%, p<0.001), and individuals carrying at least one A3 allele in their genotype had an increased risk of developing PD (odds ratio 2.78, 95% confidence interval 1.81-4.29). No significant differences were found between patients by considering the age at onset and the presence of family history or dementia. Our findings suggest a possible involvement of the tau gene in the pathogenesis of PD.